PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brheartjLink to Publisher's site
 
Br Heart J. 1980 September; 44(3): 240–247.
PMCID: PMC482392

Response of atrial flutter to overdrive atrial pacing and intravenous disopyramide phosphate, singly and in combination.

Abstract

Ten patients who suffered spontaneous paroxysms of atrial flutter were investigated by electrophysiological techniques. Two had overt Wolff-Parkinson-White syndrome; three Lown-Ganong-Levine syndrome; and one a concealed accessory atrioventricular connection. Atrial flutter was initiated, at study, by right atrial pacing and electrograms from the right atrium and coronary sinus were observed for at least five minutes to ensure stable flutter in both atria. Atrial flutter was terminated by 2.5 s or 5 s bursts of atrial pacing at rates 10, 50, or 100 beats/min faster than the intrinsic flutter rate in only two patients. Atrial flutter, which was reinitiated in two patients, was then treated with intravenous disopyramide phosphate, 2 mg/kg body weight, infused over five minutes. In all 10 patients the atrial rate slowed from a mean of 310 +/- 39 beats/min to 217 +/- 27 beats/min and atrial flutter terminated in one case. Though the mean ventricular rate fell from 161 +/- 52 beats/min to 156 +/- 45 beats/min the atrioventricular conduction ratio fell from 2.17 +/- 0.86 to 1.55 +/- 0.59 and four patients were left with symptomatically significant increases of ventricular rate. In seven of nine patients overdrive atrial pacing, repeated after disopryamide, resulted in the conversion of atrial flutter to sinus rhythm. In this study, overdrive atrial pacing and intravenous disopyramide, singly and in combination, terminated atrial flutter in nine of the 10 patients and it is suggested that this method may provide an effective alternative to direct current cardioversion.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Haft JI, Kosowsky BD, Lau SH, Stein E, Damato AN. Termination of atrial flutter by rapid electrical pacing of the atrium. Am J Cardiol. 1967 Aug;20(2):239–244. [PubMed]
  • Zeft HJ, Cobb FR, Waxman MB, Hunt NC, Morris JJ., Jr Right atrial stimulation in the treatment of atrial flutter. Ann Intern Med. 1969 Mar;70(3):447–456. [PubMed]
  • Gulotta SJ, Aronson AL. Cardioversion of atrial tachycardia and flutter by atrial stimulation. Am J Cardiol. 1970 Sep;26(3):262–269. [PubMed]
  • Pittman DE, Makar JS, Kooros KS, Joyner CR. Rapid atrial stimulation: successful method of conversion of atrial flutter and atrial tachycardia. Am J Cardiol. 1973 Oct;32(5):700–706. [PubMed]
  • Cheng TO. Atrial pacing: its diagnostic and therapeutic applications. Prog Cardiovasc Dis. 1971 Sep;14(2):230–247. [PubMed]
  • Cheng TO. Rapid atrial pacing in conversion of atrial flutter. Am J Cardiol. 1973 Feb;31(2):287–287. [PubMed]
  • Pittman DE, Gay TC, Patel II, Joyner CR. Termination of atrial flutter and atrial tachycardia with rapid atrial stimulation. Angiology. 1975 Dec;26(11):784–802. [PubMed]
  • Orlando J, Cassidy J, Aronow WS. High reversion of atrial flutter to sinus rhythm after atrial pacing in patients with pulmonary disease. Chest. 1977 May;71(5):580–582. [PubMed]
  • Waldo AL, MacLean WA, Karp RB, Kouchoukos NT, James TN. Entrainment and interruption of atrial flutter with atrial pacing: studies in man following open heart surgery. Circulation. 1977 Nov;56(5):737–745. [PubMed]
  • Hunt NC, Cobb FR, Waxman MB, Zeft HJ, Peter RH, Morris JJ., Jr Conversion of supraventricular tachycardias with atrial stimulation. Evidence for re-entry mechanisms. Circulation. 1968 Dec;38(6):1060–1065. [PubMed]
  • Puech P, Grolleau R, Latour H, Cabasson J, Robin JM, Baissus C. Traitement du flutter auriculaire par la stimulation auriculaire endocavitaire. Arch Mal Coeur Vaiss. 1973 Feb;66(2):159–167. [PubMed]
  • Rosen KM, Sinno MZ, Gunnar RM, Rahimtoola SH. Failure of rapid atrial pacing in the conversion of atrial flutter. Am J Cardiol. 1972 Apr;29(4):524–528. [PubMed]
  • Camm AJ, Ward DE, Spurrell RA. Gaps in anterograde conduction in patients with the short PR interval, normal QRS complex syndrome. Br Heart J. 1978 Oct;40(10):1119–1126. [PMC free article] [PubMed]
  • Wit AL, Cranefield PF. Triggered activity in cardiac muscle fibers of the simian mitral valve. Circ Res. 1976 Feb;38(2):85–98. [PubMed]
  • Massumi RA, Kistin AD, Tawakkol AA. Termination of reciprocating tachycardia by atrial stimulation. Circulation. 1967 Nov;36(5):637–643. [PubMed]
  • Durrer D, Schoo L, Schuilenburg RM, Wellens HJ. The role of premature beats in the initiation and the termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation. 1967 Nov;36(5):644–662. [PubMed]
  • Lister JW, Cohen LS, Bernstein WH, Samet P. Treatment of supraventricular tachycardias by rapid atrial stimulation. Circulation. 1968 Dec;38(6):1044–1059. [PubMed]
  • Vergara GS, Hildner FJ, Schoenfeld CB, Javier RP, Cohen LS, Samet P. Conversion of supraventricular tachycardias with rapid atrial stimulation. Circulation. 1972 Oct;46(4):788–793. [PubMed]
  • Ward DE, Camm AJ, Spurrell RA. The response of regular re-entrant supraventricular tachycardia to right heart stimulation. Pacing Clin Electrophysiol. 1979 Nov;2(6):586–595. [PubMed]
  • SEKIYA A, VAUGHANWILLIAMS EM. A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE. Br J Pharmacol Chemother. 1963 Dec;21:473–481. [PubMed]
  • Spurrell RA, Thorburn CW, Camm J, Sowton E, Deuchar DC. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome. Br Heart J. 1975 Aug;37(8):861–867. [PMC free article] [PubMed]
  • Birkhead JS, Vaughan Williams EM. Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. Br Heart J. 1977 Jun;39(6):657–660. [PMC free article] [PubMed]
  • Scherf D. The mechanism of flutter and fibrillation. Am Heart J. 1966 Feb;71(2):273–280. [PubMed]
  • MARQUES MG, MOTA JC, NOGUEIRA RA. The mechanism of atrial flutter. Cardiologia. 1962;40:269–280. [PubMed]
  • PRINZMETAL M, GOLDMAN A, GERLACH E, KENNAMER R. Nature of spontaneous auricular flutter in man; report of a case observed directly during cardiac surgery. J Am Med Assoc. 1953 Oct 10;153(6):553–555. [PubMed]
  • Rytand DA. The circus movement (entrapped circuit wave) hypothesis and atrial flutter. Ann Intern Med. 1966 Jul;65(1):125–159. [PubMed]
  • Gough W, Dreifus LS, de Azevedo IM, Katz MR. Refractoriness of cardiac tissue. Cardiovasc Clin. 1974;6(1):87–97. [PubMed]
  • Luoma PV, Kujala PA, Juustila HJ, Takkunen JT. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias. J Clin Pharmacol. 1978 May-Jun;18(5-6):293–301. [PubMed]
  • Vandenbosch R, Lisin N, Andriange M, Gach J, Carlier J. Experimentation clinique du disopyramide administre par voie intraveineuse. Acta Cardiol. 1975;30(4):267–278. [PubMed]
  • Deano DA, Wu D, Mautner RK, Sherman RH, Ehsani AI, Rosen KM. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate. Chest. 1977 May;71(5):597–606. [PubMed]
  • Camm J, Ward D, Spurrell RA. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias. Br J Clin Pharmacol. 1979 Nov;8(5):441–449. [PubMed]
  • ACIERNO LJ, GUBNER R. Utility and limitations of intravenous quinidine in arrhythmias. Am Heart J. 1951 May;41(5):733–741. [PubMed]
  • BROWN BB. A study of factors related to effects of quinidine in experimental auricular flutter. Circulation. 1952 Jun;5(6):864–869. [PubMed]
  • MILLER G, WEINBERG SL, PICK A. The effect of procaine amide (pronestyl) in clinical auricular fibrillation and flutter. Circulation. 1952 Jul;6(1):41–50. [PubMed]
  • Wyndham CR, Wu D, Denes P, Sugarman D, Levitsky S, Rosen KM. Self-initiated conversion of paroxysmal atrial flutter utilizing a radio-frequency pacemaker. Am J Cardiol. 1978 May 22;41(6):1119–1122. [PubMed]
  • Schamroth L, Krikler DM, Garrett C. Immediate effects of intravenous verapamil in cardiac arrhythmias. Br Med J. 1972 Mar 11;1(5801):660–662. [PMC free article] [PubMed]
  • Gianelly R, Griffin JR, Harrison DC. Propranolol in the treatment and prevention of cardiac arrhythmias. Ann Intern Med. 1967 Apr;66(4):667–676. [PubMed]
  • CASTELLANOS A, Jr, GOSSELIN A, FONSECA EJ. EVALUATION OF COUNTERSHOCK TREATMENT OF ATRIAL FLUTTER. WITH SPECIAL REFERENCE TO ARRHYTHMIAS RELATED TO THIS PROCEDURE. Arch Intern Med. 1965 Apr;115:426–433. [PubMed]
  • Lown B, Kleiger R, Williams J. Cardioversion and digitalis drugs: changed threshold to electric shock in digitalized animals. Circ Res. 1965 Dec;17(6):519–531. [PubMed]
  • RABBINO MD, LIKOFF W, DREIFUS LS. COMPLICATIONS AND LIMITATIONS OF DIRECT-CURRENT COUNTERSHOCK. JAMA. 1964 Nov 2;190:417–420. [PubMed]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group